Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biochemical acromegaly in patients with prolactinoma during treatment with dopaminergic agonists.

Arquivos brasileiros de endocrinologia e metabologia - 1 Aug 2010

Rosário Pedro W, Purisch Saulo

Abstract excerpt

OBJECTIVE: To evaluate the frequency of subclinical acromegaly (in the absence of clinical phenotype but biochemically uncontrolled) in patients with prolactinoma during treatment with dopaminergic agonists. SUBJECTS AND METHODS: One hundred twenty one patients without a phenotype suggestive of a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acromegaly
Share to Age Factors
Share to Cross-Sectional Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dopamine Agonists

Share to Human Growth Hormone

Share to Insulin-Like Growth Factor I

Share to Pituitary Neoplasms

Share to Sex Factors

Source

Identifiers

PMID: 20857059
DOI: 10.1590/s0004-27302010000600006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20857059-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biochemical acromegaly in patients with prolactinoma during treatment with dopaminergic agonists.PMID 20857059Read ↗

Management of endocrine disease: GH excess: diagnosis and medical therapy.Semantic proximity Read ↗

Acromegaly: unravelling a complex disease.Semantic proximity Read ↗

[Misleading diagnosis of hyperprolactinemia in women].Semantic proximity Read ↗

Acquired hypoprolactinemia in men, possible phenotype.Semantic proximity Read ↗

Elevated IGF-1 with GH suppression after an oral glucose overload: incipient acromegaly or false-positive IGF-1?Semantic proximity Read ↗

Long-term follow-up of patients with elevated IGF-1 and nadir GH > 0.4 µg/L but < 1 µg/L.Semantic proximity Read ↗

Prolactinomas diagnosed in the postmenopausal period: Clinical phenotype and outcomes.Semantic proximity Read ↗

Relation between serum prolactin levels and antipsychotic response to risperidone in patients with schizophrenia.Semantic proximity Read ↗

Sex-Related Difference in the Growth of Prolactinomas: A Clinical and Proliferation Marker StudySemantic proximity Read ↗

The role of endogenous growth hormone-releasing hormone in acromegaly.Semantic proximity Read ↗

Prolactin levels: sex differences in the effects of risperidone, 9-hydroxyrisperidone levels, CYP2D6 and ABCB1 variants.Semantic proximity Read ↗

Long-term metabolic and biochemical outcomes of pasireotide LAR in resistant acromegalySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.